4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-22-039463
Chief Commercial Officer sold 30,000 shares at an average $274.14 ($8,224,073)
- Chief Commercial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Option exercise | +30,000 | $60.26 | $1,807,800 | 30,000 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −593 | $266.04 | $157,762 | 29,407 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −1,107 | $267.47 | $296,089 | 28,300 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −1,913 | $268.50 | $513,641 | 26,387 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −1,476 | $269.61 | $397,944 | 24,911 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −2,069 | $270.56 | $559,789 | 22,842 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −2,084 | $271.54 | $565,889 | 20,758 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −5,534 | $272.68 | $1,509,011 | 15,224 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −2,471 | $273.54 | $675,917 | 12,753 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −3,019 | $274.56 | $828,897 | 9,734 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −811 | $275.70 | $223,593 | 8,923 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −700 | $276.67 | $193,669 | 8,223 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −700 | $277.83 | $194,481 | 7,523 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −3,003 | $279.15 | $838,287 | 4,520 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −2,620 | $279.96 | $733,495 | 1,900 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −1,000 | $280.92 | $280,920 | 900 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −400 | $282.13 | $112,852 | 500 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −400 | $283.43 | $113,372 | 100 | D |
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Sale | −100 | $284.65 | $28,465 | 0 | D |
| Derivatives | |||||||
| Sukhija Remy Chief Commercial Officer | 2022-12-23 | Option exercise · Stock Option (Right to Buy) | −30,000 | 30,000 | D | ||
| Open-market sales · 30,000 sh · avg $274.14 · $8,224,073 | |||||||
Loading xslF345X03/doc4.xml…